Free Trial
NASDAQ:HCAT

Health Catalyst (HCAT) Stock Price, News & Analysis

Health Catalyst logo
$1.33 -0.02 (-1.48%)
Closing price 04:00 PM Eastern
Extended Trading
$1.33 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Health Catalyst Stock (NASDAQ:HCAT)

Advanced

Key Stats

Today's Range
$1.28
$1.39
50-Day Range
$1.00
$1.60
52-Week Range
$0.96
$4.29
Volume
358,809 shs
Average Volume
521,382 shs
Market Capitalization
$98.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.77
Consensus Rating
Hold

Company Overview

Health Catalyst Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
66th Percentile Overall Score

HCAT MarketRank™: 

Health Catalyst scored higher than 66% of companies evaluated by MarketBeat, and ranked 382nd out of 865 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Health Catalyst has received a consensus rating of Hold. The company's average rating score is 2.23, and is based on no strong buy ratings, 4 buy ratings, 8 hold ratings, and 1 sell rating.

  • Upside Potential

    Health Catalyst has a consensus price target of $2.77, representing about 108.5% upside from its current price of $1.33.

  • Amount of Analyst Coverage

    Health Catalyst has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Health Catalyst's stock forecast and price target.
  • Earnings Growth

    Earnings for Health Catalyst are expected to grow in the coming year, from ($0.25) to ($0.24) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Health Catalyst is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Health Catalyst is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Health Catalyst has a P/B Ratio of 0.38. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Health Catalyst's valuation and earnings.
  • Percentage of Shares Shorted

    10.02% of the float of Health Catalyst has been sold short.
  • Short Interest Ratio / Days to Cover

    Health Catalyst has a short interest ratio ("days to cover") of 11.2, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Health Catalyst has recently decreased by 4.96%, indicating that investor sentiment is improving.
  • Dividend Yield

    Health Catalyst does not currently pay a dividend.

  • Dividend Growth

    Health Catalyst does not have a long track record of dividend growth.

  • News Sentiment

    Health Catalyst has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Health Catalyst this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for HCAT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Health Catalyst to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Health Catalyst insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.60% of the stock of Health Catalyst is held by insiders.

  • Percentage Held by Institutions

    85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Health Catalyst's insider trading history.
Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HCAT Stock News Headlines

ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
Health Catalyst (HCAT) Stock Trades Up, Here Is Why
Health Catalyst Reports First Quarter 2026 Results
See More Headlines

HCAT Stock Analysis - Frequently Asked Questions

Health Catalyst's stock was trading at $2.39 at the beginning of 2026. Since then, HCAT stock has decreased by 44.4% and is now trading at $1.33.

Health Catalyst, Inc. (NASDAQ:HCAT) issued its quarterly earnings data on Monday, May, 11th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.01. The firm earned $70.76 million during the quarter, compared to analyst estimates of $69.24 million. Health Catalyst had a negative net margin of 87.69% and a negative trailing twelve-month return on equity of 3.52%.
Read the conference call transcript
.

Health Catalyst (HCAT) raised $172 million in an initial public offering (IPO) on Wednesday, July 24th 2019. The company issued 7,000,000 shares at $24.00-$25.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

Top institutional shareholders of Health Catalyst include First Light Asset Management LLC (17.43%), Dimensional Fund Advisors LP (1.68%), Renaissance Technologies LLC (0.29%) and Sei Investments Co. (0.23%). Insiders that own company stock include Bryan Truman Hunt, Kevin Lee Freeman, Daniel Lesueur, Benjamin Landry, Jason Alger, Linda Llewelyn, Julie Larson-Green and Duncan Gallagher.
View institutional ownership trends
.

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), Voyager Therapeutics (VYGR) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/11/2026
Today
6/03/2026
Next Earnings (Estimated)
8/06/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Computer Software
Current Symbol
NASDAQ:HCAT
CIK
1636422
Fax
N/A
Employees
1,200
Year Founded
2008

Price Target and Rating

High Price Target
$5.00
Low Price Target
$1.00
Potential Upside/Downside
+108.5%
Consensus Rating
Hold
Rating Score (0-4)
2.23
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.72)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$177.97 million
Net Margins
-87.69%
Pretax Margin
-87.39%
Return on Equity
-3.52%
Return on Assets
-1.77%

Debt

Debt-to-Equity Ratio
1.10
Current Ratio
1.69
Quick Ratio
1.69

Sales & Book Value

Annual Sales
$311.14 million
Price / Sales
0.32
Cash Flow
$2.11 per share
Price / Cash Flow
0.63
Book Value
$3.47 per share
Price / Book
0.38

Miscellaneous

Outstanding Shares
73,890,000
Free Float
71,973,000
Market Cap
$98.27 million
Optionable
Optionable
Beta
1.66

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:HCAT) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners